Sharma Ankur Markand, Kowalski Emily, McGovern Nathan, Zhu Mingyao, Mishra Mark Vikas
Maryland Proton Treatment Center, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Int J Part Ther. 2020 Winter;6(3):19-26. doi: 10.14338/IJPT-19-00069.1. Epub 2020 Feb 21.
Total scalp irradiation (TSI) is used to treat malignancies of the scalp and face, including angiosarcomas, nonmelanoma skin cancers, and cutaneous lymphomas. Owing to the irregularity of the scalp contour and the presence of underlying critical organs at risk (OARs), radiation planning is challenging and technically difficult. To address these complexities, several different radiation therapy techniques have been used. These include the combined lateral photon-electron technique (3DRT), intensity-modulated radiation therapy (IMRT)/volumetric arc therapy (VMAT), helical tomotherapy (HT), and mold-based high-dose-rate brachytherapy (HDR BT). However, the use of proton radiation therapy (PRT) has never been documented.
A 71-year-old, immunosuppressed man presented with recurrent nonmelanoma skin cancer of the scalp. He was successfully treated at our center with PRT to deliver TSI. A comparative VMAT treatment plan was generated and dose to critical OARs was compared.
We present the first clinical case report of PRT for TSI and dosimetric comparison to a VMAT plan. The PRT and VMAT plans provided equivalent target volume coverage; however, the PRT plan significantly reduced dose to the brain, hippocampi, and optical apparatus.
TSI planned with PRT is relatively straightforward from a planning perspective and does not require a bolus. It also has the potential to decrease radiation therapy-related toxicity. However, PRT is relatively expensive and not universally available. The uncertainty surrounding the end-range of the proton beam is a consideration. Although there are potential disadvantages to using PRT for TSI, its use should be considered by treating radiation oncologists and referring physicians.
全头皮照射(TSI)用于治疗头皮和面部的恶性肿瘤,包括血管肉瘤、非黑色素瘤皮肤癌和皮肤淋巴瘤。由于头皮轮廓不规则以及存在潜在的危及器官(OARs),放射治疗计划具有挑战性且技术难度大。为应对这些复杂性,已采用了几种不同的放射治疗技术。这些技术包括联合侧方光子 - 电子技术(3DRT)、调强放射治疗(IMRT)/容积弧形调强放疗(VMAT)、螺旋断层放疗(HT)以及基于模具的高剂量率近距离放疗(HDR BT)。然而,质子放射治疗(PRT)的应用从未有过记录。
一名71岁免疫抑制男性,患有复发性头皮非黑色素瘤皮肤癌。他在我们中心成功接受了PRT以进行TSI治疗。生成了一个对比性的VMAT治疗计划,并比较了关键OARs的剂量。
我们展示了首例PRT用于TSI的临床病例报告以及与VMAT计划的剂量学比较。PRT和VMAT计划提供了等效的靶区覆盖;然而,PRT计划显著降低了对脑、海马体和光学装置的剂量。
从计划角度来看,采用PRT进行TSI相对简单,且无需使用填充物。它还有可能降低放射治疗相关的毒性。然而,PRT相对昂贵且并非普遍可用。质子束末端范围的不确定性是一个需要考虑的因素。尽管使用PRT进行TSI存在潜在缺点,但治疗放射肿瘤学家和转诊医生应考虑使用它。